Retiform Sertoli-Leydig Cell Tumor in a 38-Year-Old Woman: A Case Report, Retrospective Review, and Review of Current Literature

Table 1

Summary of immunohistochemical profile of the tumor by component.

	Positive stains	Negative stains
Solid areas (Sertoli cells)	Pancytokeratin (strong, diffuse)	CK7
	Beta-catenin (nuclear and cytoplasmic)	Glypican-3
	Calretinin	Cyclin-D1
	Inhibin	Napsin
	WT-1 (nuclear staining)	CK20
	ER	D2-40
	PR	p53
		AFP
		CD10
		HEPAR-1
		Arginase
Leydig cells	Inhibin (strong)	Pancytokeratin
	Calretinin	CK7
	Beta-catenin (nuclear and cytoplasmic)	ER
		PR
		Glypican-3
		Cyclin-D1
		Napsin
		CK20
		D2-40
		p53
		AFP
		CD10
		HEPAR-1
		Arginase
Retiform areas	Pancytokeratin (strong)	ER
	Beta-catenin (nuclear and cytoplasmic)	Glypican-3
	Calretinin	Cyclin-D1
	WT-1 (nuclear staining)	Napsin
	PR	CK20
	CK7 (weak, focal)	D2-40
	Inhibin (weak)	p53
		AFP
		CD10
		HEPAR-1
		Arginase